1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Hallmark discoveries in the biology of Wilms tumour
2023) In Nature Reviews Urology(
- Contribution to journal › Scientific review
- 2022
-
Mark
MRI Characteristics of Pediatric Renal Tumors : A SIOP-RTSG Radiology Panel Delphi Study
(
- Contribution to journal › Article
- 2021
-
Mark
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer : recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Models of care for survivors of childhood cancer from across the globe : Advancing survivorship care in the next decade
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors : a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial : A SIOP renal tumours biology consortium study
(
- Contribution to journal › Article
-
Mark
Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer : A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001) : an open-label, non-inferiority, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Multiple mechanisms of MYCN dysregulation in Wilms tumour.
(
- Contribution to journal › Article
-
Mark
Childhood cancer survivor cohorts in Europe
(
- Contribution to journal › Scientific review